1.325
0.38%
-0.005
Perspective Therapeutics Inc (CATX) 最新ニュース
Salarius Pharmaceuticals (NASDAQ:SLRX) Shares to Reverse Split on Monday, June 17th - Defense World
Defense World
Corbus Pharmaceuticals (NASDAQ:CRBP) Hits New 1-Year High Following Analyst Upgrade - Defense World
Defense World
There is no way Perspective Therapeutics Inc (CATX) can keep these numbers up – Sete News - SETE News
SETE News
Perspective Therapeutics Announces Inclusion in the Russell 3000® Index - ForexTV.com
ForexTV.com
Perspective Therapeutics Announces Inclusion in the Russell 3000® Index
GlobeNewswire Inc.
Taking a Closer Look At Perspective Therapeutics Inc (CATX) Following Its Recent Trade – Knox Daily - Knox Daily
Knox Daily
Taking a Closer Look At Perspective Therapeutics Inc (CATX) Following Its Recent Trade – Knox Daily - Knox Daily
Knox Daily
Perspective Therapeutics Inc: A Year of Highs, Lows, and Market Resilience - The InvestChronicle
The InvestChronicle
Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting - ForexTV.com
ForexTV.com
Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
GlobeNewswire Inc.
Understanding CATX's financial ratios: A beginner's guide – US Post News - US Post News
US Post News
Market Momentum: Perspective Therapeutics Inc (CATX) Registers a -6.98 Decrease, Closing at 1.20 – DWinneX - The Dwinnex
The Dwinnex
Kintara Therapeutics Inc Inc. (KTRA) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
The InvestChronicle
Perspective Therapeutics, Inc. (NYSE:CATX) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Defense World
Perspective Therapeutics, Inc. (NYSE:CATX) Receives $1.90 Average Price Target from Analysts - MarketBeat
MarketBeat
Expensify And 2 Other Stocks Under $2 Insiders Are Buying - MSN
MSN
Perspective Therapeutics Inc [AMEX: CATX] Sees Increase in Stock Value – Knox Daily - Knox Daily
Knox Daily
Spero Therapeutics (NASDAQ:SPRO) Stock Passes Below Two Hundred Day Moving Average of $1.50 - Defense World
Defense World
Perspective Therapeutics' $80 Million Shares Offering – Global Legal Chronicle - Global Legal Chronicle
Global Legal Chronicle
Expensify And 2 Other Stocks Under $2 Insiders Are Buying - MSN
MSN
Perspective Therapeutics, Inc. (NYSE:CATX) Director Lori A. Woods Buys 34246 Shares of Stock - Defense World
Defense World
Perspective Therapeutics, Inc. (NYSE:CATX) Director Robert F. Williamson III Acquires 55000 Shares - Defense World
Defense World
Perspective therapeutics director Lori Woods buys $49.9k in stock By Investing.com - Investing.com Nigeria
Investing.com Nigeria
Perspective therapeutics director Lori Woods buys $49.9k in stock By Investing.com - Investing.com Canada
Investing.com Canada
Perspective therapeutics director Lori Woods buys $49.9k in stock By Investing.com - Investing.com Australia
Investing.com Australia
Perspective therapeutics director Lori Woods buys $49.9k in stock - Investing.com India
Investing.com India
Perspective therapeutics director Lori Woods buys $49.9k in stock By Investing.com - Investing.com
Investing.com
Perspective Therapeutics, Inc. (NYSE:CATX) CFO Jonathan Robert Hunt Purchases 25006 Shares of Stock - Defense World
Defense World
CATX Stock Earnings: Perspective Therapeutics Meets EPS for Q1 2024 - MSN
MSN
Hogan Lovells advises Perspective Therapeutics in its US$80 million underwritten offering of equity securities - Legal Desire News Network
Legal Desire News Network
CATX’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
The InvestChronicle
Expensify And 2 Other Stocks Under $2 Insiders Are Buying - Expensify (NASDAQ:EXFY) - Benzinga
Benzinga
Expensify And 2 Other Stocks Under $2 Insiders Are Buying By Benzinga - Investing.com UK
Investing.com UK
Hogan Lovells advises Perspective Therapeutics in its US$80 million underwritten offering of equity securities - Legal Desire News Network
Legal Desire News Network
Perspective therapeutics director buys $75.9k in company stock By Investing.com - Investing.com Canada
Investing.com Canada
Expensify And 2 Other Stocks Under $2 Insiders Are Buying - Expensify (NASDAQ:EXFY) - Benzinga
Benzinga
Perspective therapeutics director buys $75.9k in company stock - Investing.com South Africa
Investing.com South Africa
CFO of Perspective Therapeutics buys $35,007 in company stock By Investing.com - Investing.com
Investing.com
CFO of Perspective Therapeutics buys $35,007 in company stock By Investing.com - Investing.com Canada
Investing.com Canada
Perspective Therapeutics, Inc. (NYSE:CATX) CFO Buys $35,008.40 in Stock - MarketBeat
MarketBeat
Perspective therapeutics director buys $75.9k in company stock By Investing.com - Investing.com Australia
Investing.com Australia
Perspective therapeutics director buys $75.9k in company stock By Investing.com - Investing.com
Investing.com
Avalon GloboCare Corp. (NASDAQ: ALBT) surges Over 300% Amid Promotional Activity and NASDAQ Compliance ... - BP Journal
BP Journal
Perspective therapeutics director buys $75.9k in company stock By Investing.com - Investing.com UK
Investing.com UK
Daily Progress: Perspective Therapeutics Inc (CATX) Gain 4.55, Closing at 1.38 – DWinneX - The Dwinnex
The Dwinnex
Monitoring Perspective Therapeutics Inc (CATX) after recent insider movements – Knox Daily - Knox Daily
Knox Daily
Have you been able to find a good deal on Perspective Therapeutics Inc's shares? – US Post News - US Post News
US Post News
How does Perspective Therapeutics Inc (CATX) change from a tortoise to a hare? – Sete News - SETE News
SETE News
Perspective Therapeutics, Inc. (NYSE:CATX) CFO Buys $35,008.40 in Stock - MarketBeat
MarketBeat
Insider Buying: Perspective Therapeutics, Inc. (NYSE:CATX) Director Purchases $39941.23 in Stock - Defense World
Defense World
大文字化:
|
ボリューム (24 時間):